Biomicrofluidics,
Journal Year:
2024,
Volume and Issue:
18(3)
Published: May 1, 2024
The
global
impact
of
cancer
on
human
health
has
raised
significant
concern.
In
this
context,
the
tumor
microenvironment
(TME)
plays
a
pivotal
role
in
tumorigenesis
and
malignant
progression.
order
to
enhance
accuracy
efficacy
therapeutic
outcomes,
there
is
an
imminent
requirement
for
vitro
models
that
can
accurately
replicate
intricate
characteristics
constituents
TME.
Microfluidic
devices
exhibit
notable
advantages
investigating
progression
treatment
tumors
have
potential
become
novel
methodology
evaluating
immune
cell
activities
TME
assist
clinicians
assessing
prognosis
patients.
addition,
it
shows
great
compared
traditional
experiments.
Therefore,
review
first
outlines
applications
microfluidic
chips
facilitating
culture,
constructing
activities.
Second,
roles
analysis
circulating
cells,
prognosis,
drug
screening
also
been
mentioned.
Moreover,
forward-looking
perspective
discussed,
anticipating
widespread
clinical
adoption
future.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Aug. 27, 2022
SUMMARY
Glioblastoma,
isocitrate
dehydrogenase
(IDH)-wildtype
(hereafter,
GB),
is
an
aggressive
brain
malignancy
associated
with
a
dismal
prognosis
and
poor
quality
of
life.
Single-cell
RNA
sequencing
has
helped
to
grasp
the
complexity
cell
states
dynamic
changes
in
GB.
Large-scale
data
integration
can
help
uncover
unexplored
tumor
pathobiology.
Here,
we
resolved
composition
milieu
created
cellular
map
GB
(‘GBmap’),
curated
resource
that
harmonizes
26
datasets
gathering
240
patients
spanning
over
1.1
million
cells.
We
showcase
applications
our
for
reference
mapping,
transfer
learning,
biological
discoveries.
Our
results
sources
pro-angiogenic
signaling
multifaceted
role
mesenchymal-like
cancer
Reconstructing
architecture
using
spatially
transcriptomics
unveiled
high
level
well-structured
neoplastic
niches.
The
GBmap
represents
framework
allows
streamlined
interpretation
new
provides
platform
exploratory
analysis,
hypothesis
generation
testing.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(18)
Published: March 14, 2023
Abstract
Decades
of
efforts
in
engineering
vitro
cancer
models
have
advanced
drug
discovery
and
the
insight
into
biology.
However,
establishment
preclinical
that
enable
fully
recapitulating
tumor
microenvironment
remains
challenging
owing
to
its
intrinsic
complexity.
Recent
progress
techniques
has
allowed
development
a
new
generation
can
recreate
complex
vivo
microenvironments
accurately
predict
responses,
including
spheroids,
organoids,
tumor‐on‐a‐chip.
These
biomimetic
3D
are
particular
interest
as
they
pave
way
for
better
understanding
biology
accelerating
anticancer
therapeutics
with
reducing
animal
use.
Here,
recent
advances
developing
these
platforms
modeling
screening,
focusing
on
incorporating
hydrogels
reviewed
reconstitute
physiologically
relevant
microenvironments.
The
combination
spheroids/organoids
microfluidic
technologies
is
also
highlighted
mimic
tumors
discuss
challenges
future
directions
clinical
translation
such
screening
personalized
medicine.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(21)
Published: May 26, 2022
The
perivascular
niche
(PVN)
is
a
glioblastoma
tumor
microenvironment
(TME)
that
serves
as
safe
haven
for
glioma
stem
cells
(GSCs),
and
acts
reservoir
inevitably
leads
to
recurrence.
Understanding
cellular
interactions
in
the
PVN
drive
GSC
treatment
resistance
stemness
crucial
develop
lasting
therapies
glioblastoma.
limitations
of
vivo
models
vitro
assays
have
led
critical
knowledge
gaps
regarding
influence
various
cell
types
on
GSCs
behavior.
This
study
developed
an
organotypic
triculture
microfluidic
model
means
recapitulate
its
impact
GSCs.
platform,
comprised
endothelial
(ECs),
astrocytes,
GSCs,
used
investigate
invasion,
proliferation
stemness.
Both
ECs
astrocytes
significantly
increased
invasiveness
futher
identified
15
ligand-receptor
pairs
using
single-cell
RNAseq
with
putative
chemotactic
mechanisms
where
receptor
up-regulated
diffusible
ligand
expressed
either
or
ECs.
Notably,
pair
SAA1-FPR1
demonstrated
be
involved
invasion
toward
PVN.
novel
platform
presented
herein
can
therapeutic
development
discovery
molecular
driving
biology.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(22), P. 16316 - 16316
Published: Nov. 14, 2023
Glioblastoma
is
the
most
common
malignant
primary
central
nervous
system
tumor
and
one
of
debilitating
cancers.
The
prognosis
patients
with
glioblastoma
remains
poor,
management
this
tumor,
both
in
its
recurrent
forms,
suboptimal.
Despite
tremendous
efforts
that
are
being
put
forward
by
research
community
to
discover
novel
efficacious
therapeutic
agents
modalities,
no
major
paradigm
shifts
have
been
established
field
last
decade.
However,
does
not
mirror
abundance
relevant
findings
discoveries
made
preclinical
research.
Hence,
developing
utilizing
appropriate
models
faithfully
recapitulate
characteristics
behavior
human
utmost
importance.
Herein,
we
offer
a
holistic
picture
evolution
glioblastoma.
We
further
elaborate
on
commonly
used
vitro
vivo
models,
delving
into
their
development,
favorable
characteristics,
shortcomings,
areas
potential
improvement,
which
aids
researchers
designing
future
experiments
suitable
models.
Additionally,
review
explores
progress
fields
humanized
immunotolerant
mouse
genetically
engineered
animal
3D
microfluidics
highlights
promising
avenues
for
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(14)
Published: Feb. 15, 2024
Evolving
knowledge
about
the
tumor-immune
microenvironment
(TIME)
is
driving
innovation
in
designing
novel
therapies
against
hard-to-treat
breast
cancer.
Targeting
immune
components
of
TIME
has
emerged
as
a
promising
approach
for
cancer
therapy.
While
recent
immunotherapies
aim
at
restoring
antitumor
immunity,
counteracting
tumor
escape
remains
challenging.
Hence
there
pressing
need
to
better
understand
complex
crosstalk
within
TIME.
Considering
this
imperative,
study
aims
investigating
between
two
abundant
cell
populations
TIME-macrophages
and
T
cells,
progression
using
an
organotypic
3D
vitro
tumor-on-a-chip
(TOC)
model.
The
TOC
features
distinct
yet
interconnected
stromal
entities.
This
triculture
platform
mimics
TIME,
embedding
suitable
matrix.
Analysis
invasion,
morphometric
measurements,
flow
cytometry
results
underscores
substantial
contribution
macrophages
progression,
while
presence
cells
associated
with
deceleration
migratory
behavior
both
macrophages.
Furthermore,
cytokine
analyses
reveal
significant
upregulation
leptin
RANTES
(regulated
on
activation,
normal
Cell
expressed
secreted)
triculture.
Overall,
highlights
complexity
critical
role
progression.
Lab on a Chip,
Journal Year:
2023,
Volume and Issue:
23(18), P. 3906 - 3935
Published: Jan. 1, 2023
Over
the
past
15
years,
field
of
oncology
research
has
witnessed
significant
progress
in
development
new
cell
culture
models,
such
as
tumor-on-chip
(ToC)
systems.
In
this
comprehensive
overview,
we
present
a
multidisciplinary
perspective
by
bringing
together
physicists,
biologists,
clinicians,
and
experts
from
pharmaceutical
companies
to
highlight
current
state
ToC
research,
its
unique
features,
challenges
it
faces.
To
offer
readers
clear
quantitative
understanding
field,
conducted
an
extensive
systematic
analysis
more
than
300
publications
related
2005
2022.
key
advantages
over
other
vitro
models
enabling
precise
control
various
parameters.
These
parameters
include
properties
extracellular
matrix,
mechanical
forces
exerted
on
cells,
physico-chemical
environment,
composition,
architecture
tumor
microenvironment.
Such
fine
allows
closely
replicate
complex
microenvironment
interactions
within
tumors,
facilitating
study
cancer
progression
therapeutic
responses
highly
representative
manner.
Importantly,
incorporating
patient-derived
cells
or
xenografts,
have
demonstrated
promising
results
terms
clinical
validation.
We
also
examined
potential
for
industries
which
adoption
is
expected
occur
gradually.
Looking
ahead,
given
high
failure
rate
trials
increasing
emphasis
3Rs
principles
(replacement,
reduction,
refinement
animal
experimentation),
hold
immense
research.
next
decade,
data
generated
could
potentially
be
employed
discovering
targets,
contributing
regulatory
purposes,
refining
preclinical
drug
testing
reducing
reliance
models.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(30)
Published: April 5, 2024
Abstract
The
coordinated
migration
of
invasive
tumor
cells
is
a
complex
and
dynamic
mechanism
driven
by
diverse
cellular
molecular
events.
Unfortunately,
the
inherent
heterogeneity
within
tumors
raises
multiple
challenges
in
deciphering
key
biomarkers
novel
therapeutic
approaches
to
prevent
metastasis.
Here,
microengineered
tumor‐on‐a‐chip
system
incorporating
human
platelet
lysate
hydrogels
proposed
recreate
early
metastatic
process
invasion
drug
response.
By
co‐culturing
bone
marrow
mesenchymal
stem
with
two
cell
lines
distinct
capability,
developed
model
can
emulate
3D
microarchitecture
inter‐heterogeneity
regarding
its
intrinsic
ability.
recreated
microenvironment
supports
stromal
movement,
evidencing
synergistic
tumor‐stromal
cell‐extracellular
matrix
interactions
an
invading
tumor.
Through
gene
protein
expression
analysis
exometabolomic
profiling,
this
platform
provides
evidence
for
role
environment
as
regulator
Additionally,
effect
doxorubicin
treatment
on
invasiveness
biomarker
profile
highlights
suitability
established
models
therapy
assessment.
Overall,
study
presents
useful
pursue
mechanistic
studies
events
fully
human‐derived
microenvironment,
while
contributing
fundamental
insights
into
biomolecular
profiling.